Patents 11show all

  • 7
    A61K - Preparations for medical, dental, or toilet purposes
  • 7
    C07C - Acyclic or carbocyclic compounds
  • 7
    C07D - Heterocyclic compounds
  • 7
    C07H - Sugars

Clinical Trials 5show all

2Phase 12Phase 21N/A

SEC Filings show all


64
8-K

26
10-Q

10
D

9
10-K

1
S-1

Contact Information

Boston, MA
United States

SEC Form D Funding Events

DateOfferedSoldType
2014-07-28$2,000,000$1,222,500Debt
2014-01-10$2,000,000$877,500Equity, Option to Acquire, Security to be Acquired
2013-09-27$7,000,000$737,500Equity, Debt, Security to be Acquired
2013-07-08$500,000$250,000Debt
2012-11-21$4,000,000$1,546,250Equity, Option to Acquire
2011-07-07$6,000,000$2,355,621Equity, Option to Acquire
2011-06-01$6,000,000$3,667,442Equity, Option to Acquire
2007-06-06Unknown Unknown Other (Paper Filing)

Key Executives

  • Johan (Thijs) M. Spoor
    Executive Officer, Director
  • David R. Elmaleh
    Executive Officer, Director
  • Walter Witshkin
    Director
  • Peter S. Conti
    Director
  • Johan (Thijs) Spoor
    Executive Officer, Director
  • Tamara Rhein
    Executive Officer
  • Walter Witoshkin
    Director
  • Peter Conti
    Director
  • Lawrence Atinsky
    Director
  • Joseph Pierro
    Director
  • Johan (Thjis) Spoor
    Executive Officer, Director
  • Joseph A. Pierro
    Director
  • Andrew H. Sassine
    Director